Logo image of MRSN

MERSANA THERAPEUTICS INC (MRSN) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:MRSN - US59045L2051 - Common Stock

29.08 USD
+0.04 (+0.14%)
Last: 1/5/2026, 8:00:00 PM
29.3 USD
+0.22 (+0.76%)
After Hours: 1/5/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MRSN revenue by date.MRSN revenue by date.
26.58M
66,350.00%
36.855M
38.66%
40.497M
9.88%
23.762M
-41.32%
20.893M
-12.07%
10.455M
-49.96%
60.823M
481.76%
129.24M
112.49%
162.39M
25.65%
186.49M
14.84%
207.58M
11.31%
233.77M
12.62%
EBITDA
YoY % growth
MRSN ebitda by date.MRSN ebitda by date.
-202.84M
-20.74%
-169.44M
16.47%
-71.708M
57.68%
-116.28M
-62.16%
-137.7M
-18.42%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MRSN ebit by date.MRSN ebit by date.
-203.77M
-20.67%
-170.957M
16.10%
-73.336M
57.10%
-77.021M
-5.02%
-79.537M
-3.27%
-108.41M
-36.30%
-103.137M
4.86%
-63.704M
38.23%
-32.9M
48.35%
8.094M
124.60%
30.845M
281.08%
33.186M
7.59%
Operating Margin
MRSN operating margin by date.MRSN operating margin by date.
-766.63%-463.86%-181.09%-324.14%-380.69%-1,036.92%-169.57%-49.29%-20.26%4.34%14.86%14.20%
EPS
YoY % growth
MRSN eps by date.MRSN eps by date.
-54.75
8.75%
-35.50
35.16%
-14.00
60.56%
-8.50
39.26%
-9.84
-15.71%
-10.56
-7.29%
-4.95
53.14%
-5.40
-9.07%
59.93
1,210.59%
72.68
21.28%
80.33
10.53%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
-3.30
-19.86%
-3.41
28.18%
-2.87
40.98%
-2.83
-87.45%
-2.75
16.68%
-3.66
-7.34%
-3.62
-25.98%
-3.96
-39.82%
-3.93
-42.99%
-4.95
-35.10%
-5.63
-55.49%
-6.29
-59.02%
-8.42
-114.29%
Revenue
Q2Q % growth
5.193M
-68.26%
2.662M
-3.34%
2.662M
-12.89%
2.662M
-75.82%
2.537M
-51.15%
3.06M
14.95%
3.06M
14.95%
3.06M
14.95%
3.06M
20.61%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-17.766M
-19.95%
-25.908M
-5.70%
-25.908M
-25.91%
-25.908M
-246.55%
-25.908M
-45.83%
N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.51
32.89%
-1.640.138.12%
Q2 2025
Q2Q % growth
-4.87
2.60%
-4.01-0.86-21.54%
Q1 2025
Q2Q % growth
-4.75
-18.75%
-4.950.203.98%
Q4 2024
Q2Q % growth
-2.75
31.25%
-4.111.3633.06%
Q3 2024
Q2Q % growth
-2.25
66.67%
-4.472.2249.71%
Q2 2024
Q2Q % growth
-5.00
57.45%
-4.37-0.63-14.37%
Q1 2024
Q2Q % growth
-4.00
69.23%
-4.620.6213.34%
Q4 2023
Q2Q % growth
-4.00
63.64%
-4.190.194.54%
Q3 2023
Q2Q % growth
-6.75
55.74%
-9.232.4826.85%
Q2 2023
Q2Q % growth
-11.75
14.55%
-11.26-0.49-4.38%
Q1 2023
Q2Q % growth
-13.00
11.86%
-11.11-1.89-16.99%
Q4 2022
Q2Q % growth
-11.00
35.29%
-12.861.8614.48%
Q3 2022
Q2Q % growth
-15.25
3.17%
-2.30-12.96-564.49%
Q2 2022
Q2Q % growth
-13.75
6.78%
-13.26-0.49-3.70%
Q1 2022
Q2Q % growth
-14.75
-18.00%
-8.12-6.63-81.57%
Q4 2021
Q2Q % growth
-17.00
-61.90%
-17.050.050.28%
Q3 2021
Q2Q % growth
-15.75
-90.91%
-14.79-0.96-6.49%
Q2 2021
Q2Q % growth
-14.75
-78.79%
-12.71-2.04-16.07%
Q1 2021
Q2Q % growth
-12.50
-42.86%
-10.07-2.43-24.10%
Q4 2020
Q2Q % growth
-10.50 -8.27-2.23-26.97%
Q3 2020
Q2Q % growth
-8.25 -7.78-0.47-6.08%
Q2 2020
Q2Q % growth
-8.25 -7.61-0.64-8.45%
Q1 2020
Q2Q % growth
-8.75 -9.510.767.97%
MRSN Yearly EPS VS EstimatesMRSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 50 -50 -100 -150 -200
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
11.009M
-12.61%
14.482M-3.473M-23.98%
Q2 2025
Q2Q % growth
3.056M
33.28%
6.49M-3.434M-52.91%
Q1 2025
Q2Q % growth
2.754M
-70.21%
5.957M-3.203M-53.77%
Q4 2024
Q2Q % growth
16.361M
52.89%
7.831M8.53M108.93%
Q3 2024
Q2Q % growth
12.598M
63.65%
7.681M4.917M64.02%
Q2 2024
Q2Q % growth
2.293M
-78.48%
8.896M-6.603M-74.22%
Q1 2024
Q2Q % growth
9.245M
18.50%
8.67M575K6.63%
Q4 2023
Q2Q % growth
10.701M
-27.15%
15.068M-4.367M-28.98%
Q3 2023
Q2Q % growth
7.698M
38.20%
9.537M-1.839M-19.28%
Q2 2023
Q2Q % growth
10.654M
148.93%
13.214M-2.56M-19.37%
Q1 2023
Q2Q % growth
7.802M
282.45%
18.651M-10.849M-58.17%
Q4 2022
Q2Q % growth
14.69M
146,800.00%
15.589M-899K-5.77%
Q3 2022
Q2Q % growth
5.57M
55,600.00%
35.879M-30.309M-84.48%
Q2 2022
Q2Q % growth
4.28M
42,700.00%
2.246M2.034M90.56%
Q1 2022
Q2Q % growth
2.04M
20,300.00%
8.308M-6.268M-75.45%
Q4 2021
Q2Q % growth
10K 3.743K6.257K167.14%
Q3 2021
Q2Q % growth
10K 105.356K-95.356K-90.51%
Q2 2021
Q2Q % growth
10K
-98.75%
144.503K-134.503K-93.08%
Q1 2021
Q2Q % growth
10K 326.4K-316.4K-96.94%
Q4 2020
Q2Q % growth
10K 171.87K-161.87K-94.18%
Q3 2020
Q2Q % growth
10K 447.984K-437.984K-97.77%
Q2 2020
Q2Q % growth
800K 306K494K161.44%
Q1 2020
Q2Q % growth
10K 399.503K-389.503K-97.50%
MRSN Yearly Revenue VS EstimatesMRSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -11.77% 0% 4.28%
Revenue0% -3.76% 0% -7.9%